308.22
                                            
            Beone Medicines Ltd Adr stock is traded at $308.22, with a volume of 190.49K.
            It is down -2.11% in the last 24 hours and down -9.53% over the past month.
            Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
        
        See More
    Previous Close:
              $314.85
            Open:
              $310.19
            24h Volume:
                190.49K
            Relative Volume:
              0.63
            Market Cap:
                $33.80B
            Revenue:
              $4.56B
            Net Income/Loss:
              $-176.77M
            P/E Ratio:
              -179.44
            EPS:
                -1.7177
            Net Cash Flow:
                $225.30M
            1W Performance:
              -0.58%
            1M Performance:
              -9.53%
            6M Performance:
                +18.63%
            1Y Performance:
              +0.00%
            Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
                  
                      Beone Medicines Ltd Adr
                    
                Sector
                  Industry
                  Phone
                  
                      41-616851900
                    
                Address
                  
                      C/O BEONE MEDICINES I GMBH, BASEL
                    
                Compare ONC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                ONC
                            
                             Beone Medicines Ltd Adr | 308.22 | 34.58B | 4.56B | -176.77M | 225.30M | -1.7177 | 
|   
                          
                                VRTX
                            
                             Vertex Pharmaceuticals Inc | 419.89 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 | 
|   
                          
                                REGN
                            
                             Regeneron Pharmaceuticals Inc | 654.04 | 68.62B | 14.25B | 4.58B | 3.88B | 41.77 | 
|   
                          
                                ALNY
                            
                             Alnylam Pharmaceuticals Inc | 449.56 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 | 
|   
                          
                                ARGX
                            
                             Argen X Se Adr | 820.36 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 | 
|   
                          
                                INSM
                            
                             Insmed Inc | 194.22 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 | 
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Sep-18-25 | Initiated | Barclays | Overweight | 
| Apr-07-25 | Initiated | RBC Capital Mkts | Outperform | 
| Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy | 
| Dec-03-24 | Resumed | Morgan Stanley | Overweight | 
| Sep-18-24 | Initiated | JMP Securities | Mkt Outperform | 
| Feb-06-24 | Resumed | JP Morgan | Overweight | 
| Sep-12-23 | Initiated | Macquarie | Outperform | 
| Aug-17-23 | Initiated | Jefferies | Buy | 
| Jul-17-23 | Initiated | Citigroup | Buy | 
| Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform | 
| Jan-12-23 | Initiated | Daiwa Securities | Buy | 
| Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy | 
| Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform | 
| Aug-09-22 | Resumed | JP Morgan | Overweight | 
| Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform | 
| Feb-07-22 | Initiated | Deutsche Bank | Buy | 
| Oct-12-21 | Initiated | Bernstein | Outperform | 
| Oct-06-21 | Upgrade | CLSA | Underperform → Buy | 
| Mar-08-21 | Initiated | China Renaissance | Buy | 
| Mar-01-21 | Downgrade | CLSA | Outperform → Underperform | 
| Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral | 
| Nov-06-20 | Downgrade | Maxim Group | Buy → Hold | 
| Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight | 
                    View All
                     
                  
                Beone Medicines Ltd Adr Stock (ONC) Latest News
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Oppenheimer Asset Management Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.
Allianz Asset Management GmbH Acquires Shares of 3,300 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
DekaBank Deutsche Girozentrale Purchases Shares of 13,600 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Yousif Capital Management LLC Invests $368,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Sequoia Financial Advisors LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Janney Montgomery Scott LLC Takes $373,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Callan Family Office LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,002 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by IFP Advisors Inc - MarketBeat
Free cash flow per share of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Blue Trust Inc. Buys New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Net income before discontinued operations of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
Operating expenses (excl. COGS) of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
BeOne Medicines (NASDAQ:ONC) SVP Sells $3,739,118.40 in Stock - MarketBeat
Venturi Wealth Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys Shares of 3,824 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. Sponsored ADR (ONC) Stock Price Today | Live Chart & News - Traders Union
160 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Acquired by Farther Finance Advisors LLC - Defense World
Slow Capital Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Signaturefd LLC Purchases New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
PFG Investments LLC Acquires Shares of 985 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
14,420 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - Defense World
14,420 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - MarketBeat
Perigon Wealth Management LLC Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
LVW Advisors LLC Purchases Shares of 1,022 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Aaron Wealth Advisors LLC Invests $200,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Brokerages Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Target Price at $336.30 - Defense World
John Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
Avanza Fonder AB Makes New $199,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App